Aliski William Insider Trading

Get the latest insider transactions of Aliski William. Aliski William is Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in X4 Pharmaceuticals, Inc ($ASNS) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE). Discover the current value of Aliski William shares.

Address: C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO 94949CA

Aliski William is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
RAREUltragenyx Pharmaceutical Inc.Director57,0184,157,182.38
AGTCAPPLIED GENETIC TECHNOLOGIES CORPDirector3,70023,865.00
ASNSX4 Pharmaceuticals, IncDirector0

Insider Trading Transactions of Aliski William

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jun 30 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy0.002,550057,018
Jun 30 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise76.584,250325,4654,250
Jun 11 2020ASNSX4 Pharmaceuticals, IncAliski WilliamDirectorOption Exercise8.693,42729,7813,427
Jun 03 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell74.0220,0001,480,32270,350
May 20 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy40.377,500302,77555,424
May 20 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell74.657,500559,87547,924
May 20 2020RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise40.377,500302,7750
Dec 06 2019AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorOption Exercise3.0210,00030,20010,000
Sep 20 2019ASNSX4 Pharmaceuticals, IncAliski WilliamDirectorOption Exercise14.046,85496,2306,854
Sep 20 2019ASNSX4 Pharmaceuticals, IncAliski WilliamDirectorOption Exercise14.046,85496,2306,854
Jun 13 2019RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy0.003,000047,924
Jun 13 2019RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise58.745,000293,7005,000
Dec 18 2018AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorBuy3.241,2003,8823,700
Dec 18 2018AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorBuy3.254,30013,9758,000
Dec 18 2018AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorBuy3.245001,6208,500
Dec 07 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell49.696,000298,14090,350
Nov 19 2018AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorOption Exercise6.9010,00069,00010,000
Nov 08 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell55.676,000334,02096,350
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy0.0084,9700121,900
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell68.6510,500720,825111,400
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell85.942,000171,880109,400
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell122.5840049,032109,000
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell53.9765035,081108,350
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell73.386,000440,280102,350
Oct 09 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise0.00266,34300
Sep 24 2018AGTCAPPLIED GENETIC TECHNOLOG ...Aliski WilliamDirectorOption Exercise4.4025,000110,00025,000
Aug 08 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell76.663,750287,47572,610
Jun 20 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy0.003,000076,360
Jun 20 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise80.695,000403,4505,000
Jan 25 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy21.0011,500241,50073,360
Jan 25 2018RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise21.0011,500241,5000
Jun 22 2017RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy0.001,875061,860
Jun 22 2017RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise65.663,750246,2253,750
Dec 05 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamBuy21.006,000126,00065,985
Dec 05 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamSell77.944,000311,76061,985
Dec 05 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamSell78.702,000157,40059,985
Dec 05 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamOption Exercise21.006,000126,00011,500
Jun 14 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamBuy0.001,875059,985
Jun 14 2016RAREUltragenyx Pharmaceutical ...Aliski WilliamOption Exercise65.853,750246,9383,750
Jun 22 2015RAREUltragenyx Pharmaceutical ...Aliski WilliamOption Exercise97.857,500733,8757,500
Dec 08 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell41.832,891120,92963,119
Dec 08 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorSell42.463,109132,01360,010
Oct 22 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy3.0129,10887,61566,010
Oct 22 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise3.0129,10887,6150
Jul 17 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise40.377,500302,7757,500
Feb 07 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise0.9691,24187,5000
Feb 07 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise3.0129,10887,6150
Feb 03 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorBuy21.005,000105,00036,903
Feb 03 2014RAREUltragenyx Pharmaceutical ...Aliski WilliamDirectorOption Exercise21.0017,500367,50017,500